Buy Retatrutide 10mg | HelixaMed

Retatrutide (triple receptor agonist) — research peptide

Retatrutide is a next-generation research peptide that acts on three metabolic receptors at once — GIP, GLP-1 and glucagon. That triple action is what sets it apart from single- and dual-agonist peptides and why it has drawn so much attention in metabolic and body-composition research. HelixaMed supplies it as a lyophilised (freeze-dried) research compound, verified for identity and concentration before it ships.

Because it arrives freeze-dried, retatrutide must be reconstituted with bacteriostatic water and kept cold — degraded peptide simply does not behave as expected in a study. Our reconstitution guide walks through preparing and storing it correctly so a protocol runs on stable, accurate material. This is a research-use product; we do not provide dosing protocols or human-use guidance.

• Triple mechanism: GIP, GLP-1 and glucagon receptor activity in one molecule.
• Tested identity: lyophilised vial with verifiable batch analysis.
• Handle correctly: reconstitute with bacteriostatic water, store cold.